Charles Russell Speechlys advises MedPass International on the sale of the company to Icon plc

Charles Russell Speechlys advised the shareholders of Medpass International, the leading European medical device CRO, regulatory and reimbursement consultancy, on the sale of the company to Icon plc, a NASDAQ listed global provider of drug and device development and commercialisation services.


Post a Press Release


Browse Top 1000 Lists


This transaction will further expand ICON’s global medical device and diagnostic research services.

The team at Charles Russell Speechlys was led by Corporate Partner Richard Norton with assistance from Paris based partner Thibaut Caharel and London based tax partner Robert Birchall.


More from: | Category: Legal Company News